Please rate this video

ASCO 2019 | Individualized therapy in waldenström’s macroglobulinemia

Please rate this video

Jithma Abeykoon

Jithma Abeykoon, MD, PhD, of the Mayo Clinic, Rochester, MN, explains the importance of individualized therapy in waldenström’s macroglobulinemia. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter